
- Oncology NEWS International Vol 7 No 2
- Volume 7
- Issue 2
NCI Funds DDT-Breast Disease Study
BETHESDA, Md-The possible link between the pesticide DDT and breast cancer or benign breast disease will be explored among women in the northern Alabama community of Triana. The study by researchers from the National Cancer Institute and the University of Alabama in Huntsville College of Nursing will begin Feb. 15, with results available in 1999.
BETHESDA, MdThe possible link between the pesticide DDT and breast cancer or benign breast disease will be explored among women in the northern Alabama community of Triana. The study by researchers from the National Cancer Institute and the University of Alabama in Huntsville College of Nursing will begin Feb. 15, with results available in 1999.
In the early 1970s, body burdens of DDT were found to average 10 times greater in Triana residents, the result of consuming fish contaminated with DDT dumped into the Tennessee River from a pesticide-processing plant.
Researchers will evaluate blood concentrations of DDT and its metabolite DDE in women diagnosed with breast cancer, benign breast disease, or dense breast tissues, and compare their pesticide levels with those of women in the study who are free of these conditions.
Articles in this issue
over 27 years ago
Tobacco Companies Reach Settlement With Texas for $15.3 Billionover 27 years ago
Archives to Collect Info on Radiation Exposure Worldwideover 27 years ago
Few BRCA-1 Carriers Take Recommended Precautionsover 27 years ago
Lifelong Weight Control a Key to Breast Ca Preventionover 27 years ago
Eight-Year Prostate Brachytherapy Update Shows Good Resultsover 27 years ago
Patient Brochure on Breast Cancer Tumor Markersover 27 years ago
Gay Men’s Health Crisis Calls for HIV Reporting in New Yorkover 27 years ago
Single-Agent Taxanes in Advanced Breast Cancer: A Commentaryover 27 years ago
ODAC Declines to Vote on DepoCyt FDA Recommendationover 27 years ago
Photofrin Approved for Early-Stage Lung CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.